Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Alimera Sciences To Report Second Quarter 2017 Financial Results On August 2nd, 2017 July 23, 2017 Avita Medical Taps Investors for A$16.9 Million to Commercialise Its 'Spray-On Skin' October 10, 2017 The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017
Avita Medical Taps Investors for A$16.9 Million to Commercialise Its 'Spray-On Skin' October 10, 2017
The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017
